FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira a Pfizer Neut Sodium Bicarbonate 4% Recall

Neut Sodium Bicarbonate 4% (2

Hospira a Pfizer Company · Rocky Mount, NC

Risk level
Class II
Reported by FDA
Aug 9, 2017
Recall ID
D-1049-2017
Check your lot numberHow we source this data

Summary

Hospira a Pfizer recalled Neut Sodium Bicarbonate 4% starting Jun 15, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1049-2017 on Aug 9, 2017. Reason: Lack of Sterility Assurance. Status: Terminated.

Why it was recalled

Lack of Sterility Assurance

Product description

Neut Sodium Bicarbonate 4% (2.4 mEq) Additive Solution 5 mL , a.) Single-dose vial (NDC 0409-6609-02), b.) 25 vial carton (NDC 0409-6609-25), Rx Only, Mfd by Hospira, INC, Lake Forest, IL 60045 USA

Lot numbers, UPCs & expiration codes

a.) one vial: Lot: 72226EV Exp. 12/01/2018 Lot: 72236EV Exp. 12/01/2018 Lot: 75382EV Exp. 03/01/2019 Lot: 75383EV Exp. 03/01/2019 b.) 25 vial carton: Lot: 7538EV; Exp 03/01/2019

Where it was sold

U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1049-2017
Classification
Class II
Status
Terminated
Recall initiated
Jun 15, 2017
FDA report date
Aug 9, 2017
Quantity
21,436,700 5mL single dose vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira a Pfizer Company

Original FDA data

Every field from FDA enforcement report D-1049-2017, exactly as published.

Show all FDA fields
City
Rocky Mount
State
NC
Status
Terminated
Country
United States
Event ID
77533
Address
4285 N Wesleyan Blvd
Code information
a.) one vial: Lot: 72226EV Exp. 12/01/2018 Lot: 72236EV Exp. 12/01/2018 Lot: 75382EV Exp. 03/01/2019 Lot: 75383EV Exp. 03/01/2019 b.) 25 vial carton: Lot: 7538EV; Exp 03/01/2019
Postal code
27804-8612
Report date
Aug 9, 2017
Product type
Drugs
Recall number
D-1049-2017
Classification
Class II
Recalling firm
Hospira a Pfizer Company
Product quantity
21,436,700 5mL single dose vials
Termination date
Jul 20, 2020
Reason for recall
Lack of Sterility Assurance
Voluntary / mandated
Voluntary: Firm initiated
Product description
Neut Sodium Bicarbonate 4% (2.4 mEq) Additive Solution 5 mL , a.) Single-dose vial (NDC 0409-6609-02), b.) 25 vial carton (NDC 0409-6609-25), Rx Only, Mfd by Hospira, INC, Lake Forest, IL 60045 USA
Distribution pattern
U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore
Recall initiation date
Jun 15, 2017
Initial firm notification
Press Release
Center classification date
Aug 1, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1049-2017, published Aug 9, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls